Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients



Status:Recruiting
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/8/2018
Start Date:June 2016
End Date:July 2019
Contact:George Guldan, MD
Email:guldan@musc.edu
Phone:843-7922322

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The objective of this prospective, randomized controlled study is to ascertain whether the
perioperative use of the FloTrac device to guide fluid and vasopressor management during
esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary
complications; however, the secondary outcome of decreasing patient morbidity (acute renal
injury, anastomotic leak, and overall length of both ICU (intensive care unit) and hospital
stay.


Inclusion Criteria:

- Patients 18 years of age or older

- Patients undergoing primary resection of esophageal cancer and resultant
esophagectomy.

Exclusion Criteria:

- Patients < 55kg or > 140 kg, based on literature regarding accuracy of FloTrac.

- Patients with sustained preoperative dysrhythmias, based on literature regarding
accuracy of FloTrac (atrial flutter and/or atrial fibrillation).

- Patients with diagnosed NYHA class III-IV failure or documented EF < 30%

- Patients who are unable/unwilling to consent for study procedures
We found this trial at
1
site
Medical University of South Carolina
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: George Guldan, MD
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials